1. Home
  2. ARDX vs WEN Comparison

ARDX vs WEN Comparison

Compare ARDX & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.97

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$6.83

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
WEN
Founded
2007
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
ARDX
WEN
Price
$6.97
$6.83
Analyst Decision
Strong Buy
Hold
Analyst Count
7
22
Target Price
$15.14
$8.84
AVG Volume (30 Days)
3.8M
7.4M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
8.28%
EPS Growth
N/A
N/A
EPS
N/A
0.85
Revenue
$2,607,000.00
$2,176,891,000.00
Revenue This Year
$37.75
$2.26
Revenue Next Year
$34.24
$0.94
P/E Ratio
N/A
$7.79
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$6.37
52 Week High
$8.40
$12.52

Technical Indicators

Market Signals
Indicator
ARDX
WEN
Relative Strength Index (RSI) 62.75 45.87
Support Level $6.83 $6.73
Resistance Level $8.23 $7.28
Average True Range (ATR) 0.36 0.24
MACD 0.11 -0.02
Stochastic Oscillator 69.88 42.63

Price Performance

Historical Comparison
ARDX
WEN

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

Share on Social Networks: